|
Originally published In Press as doi:10.1074/jbc.M702746200 on September 12, 2007
J. Biol. Chem., Vol. 282, Issue 45, 32710-32718, November 9, 2007
Temperature-dependent Modulation of CaV3 T-type Calcium Channels by Protein Kinases C and A in Mammalian Cells*
Jean Chemin 1,
Alexandre Mezghrani ,
Isabelle Bidaud 2,
Sebastien Dupasquier 3,
Fabrice Marger 4,
Christian Barrère ,
Joël Nargeot , and
Philippe Lory
From the
Département de Physiologie and the Département d'Oncologie Moléculaire et Cellulaire, Institut de Génomique Fonctionnelle, CNRS UMR 5203, INSERM U661, Universités de Montpellier 1 et 2, Institut Fédératif de Recherche 3, Montpellier 34094, France
Modulation of low voltage-activated CaV3 T-type calcium channels remains poorly characterized compared with high voltage-activated CaV1 and CaV2 calcium channels. Notably, it is yet unresolved whether CaV3 channels are modulated by protein kinases in mammalian cells. In this study, we demonstrate that protein kinase A (PKA) and PKC (but not PKG) activation induces a potent increase in CaV3.1, CaV3.2, and CaV3.3 currents in various mammalian cell lines. Notably, we show that protein kinase effects occur at physiological temperature ( 30–37 °C) but not at room temperature ( 22–27 °C). This temperature dependence could involve kinase translocation, which is impaired at room temperature. A similar temperature dependence was observed for PKC-mediated increase in high voltage-activated CaV2.3 currents. We also report that neither CaV3 surface expression nor T-current macroscopic properties are modified upon kinase activation. In addition, we provide evidence for the direct phosphorylation of CaV3.2 channels by PKA in in vitro assays. Overall, our results clearly establish the role of PKA and PKC in the modulation of CaV3 T-channels and further highlight the key role of the physiological temperature in the effects described.
Received for publication, March 30, 2007
, and in revised form, September 12, 2007.
* This work was supported in part by CNRS; Agence Nationale de la Recherche Research Grant ANR-05-NEUR-031; and research grants from Agence de Recherche contre le Cancer-Institut contre le Cancer 2006, the Institut UPSA de la Douleur, and the Association Française contre les Myopathies. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1 and 2.
2 Supported by the Ligue Francaise contre l'Épilepsie.
3 Supported by the Ligue Régionale contre le Cancer (Languedoc-Roussillon).
4 Supported by a grant from Pfizer France.
1 To whom correspondence should be addressed: Dépt. de Physiologie, Inst. de Génomique Fonctionnelle, 141, Rue de la Cardonille, Montpellier 34094, France. Tel.: 33-499-619-939; Fax: 33-499-619-901; E-mail: jean.chemin{at}igf.cnrs.fr.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Hu, S. D. DePuy, J. Yao, W. E. McIntire, and P. Q. Barrett
Protein Kinase A Activity Controls the Regulation of T-type CaV3.2 Channels by G{beta}{gamma} Dimers
J. Biol. Chem.,
March 20, 2009;
284(12):
7465 - 7473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tao, M. E. Hildebrand, P. Liao, M. C. Liang, G. Tan, S. Li, T. P. Snutch, and T. W. Soong
Activation of Corticotropin-Releasing Factor Receptor 1 Selectively Inhibits CaV3.2 T-Type Calcium Channels
Mol. Pharmacol.,
June 1, 2008;
73(6):
1596 - 1609.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|